GMO Beyond China ETF (BCHI) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
GMO Beyond China ETF (BCHI) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $18.4M, listed on AMEX, carrying a beta of 1.03 to the broader market. The GMO Beyond China ETF seeks to deliver total return by investing primarily in equities of companies positioned to benefit from the trend of companies diversifying supply chains, excluding Chinese securities. public since 2025-02-13.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for BCHI as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.